Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement

被引:8
|
作者
Swiderek-Matysiak, Mariola [1 ]
Oset, Magdalena [1 ]
Domowicz, Malgorzata [1 ]
Galazka, Grazyna [1 ]
Namiecinska, Magdalena [1 ]
Stasiolek, Mariusz [1 ]
机构
[1] Med Univ Lodz, Dept Neurol, Kosciuszki St 4, PL-90419 Lodz, Poland
关键词
multiple sclerosis; differential diagnosis; cerebrospinal fluid; oligoclonal bands; neurofilaments light chain; interleukin; 6; osteopontin; FIBRILLARY ACIDIC PROTEIN; NEUROMYELITIS-OPTICA; LUPUS-ERYTHEMATOSUS; OSTEOPONTIN LEVELS; MISDIAGNOSIS; NEUROFILAMENT; CXCL13; SPECIFICITY; MARKERS; CSF;
D O I
10.3390/biomedicines11020425
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In total, 242 CSF samples were collected from patients undergoing differential MS diagnosis because of the presence of T2-hyperintensive lesions on brain MRI. The non-MS patients were subdivided into systemic inflammatory diseases with CNS involvement (SID) or cerebrovascular diseases (CVD) or other non-inflammatory diseases (NID). All samples were analyzed for the presence of oligoclonal bands and ELISA was performed for detection of: INF gamma, IL-6, neurofilaments light chain (NF-L), GFAP, CHI3L1, CXCL13, and osteopontin. Results: The level of IL-6 (p = 0.024), osteopontin (p = 0.0002), and NF-L (p = 0.002) was significantly different among groups. IL-6 (p = 0.0350) and NF-L (p = 0.0015) level was significantly higher in SID compared to NID patients. A significantly higher level of osteopontin (p = 0.00026) and NF-L (p = 0.002) in MS compared to NID population was noted. ROC analysis found weak diagnostic power for osteopontin and NFL-L. Conclusions: The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Place and role of cerebrospinal fluid in diagnosis of diseases of central nervous system
    Ciric, D
    Bogdanovic, S
    Ciric, M
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1996, 15 (04): : 245 - 245
  • [2] NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system
    French, Caitlin D.
    Willoughby, Rodney E.
    Pan, Amy
    Wong, Susan J.
    Foley, John F.
    Wheat, L. Joseph
    Fernandez, Josefina
    Encarnacion, Rafael
    Ondrush, Joanne M.
    Fatteh, Naaz
    Paez, Andres
    David, Dan
    Javaid, Waleed
    Amzuta, Ioana G.
    Neilan, Anne M.
    Robbins, Gregory K.
    Brunner, Andrew M.
    Hu, William T.
    Mishchuk, Darya O.
    Slupsky, Carolyn M.
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (12):
  • [3] Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
    Wullschleger, Alexandre
    Kapina, Viktoria
    Molnarfi, Nicolas
    Courvoisier, Delphine S.
    Seebach, Joerg D.
    Santiago-Raber, Marie-Laure
    Hochstrasser, Denis F.
    Lalive, Patrice H.
    PLOS ONE, 2013, 8 (08):
  • [4] Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system
    Oreja-Guevara, C
    Sindern, E
    Raulf-Heimsoth, M
    Malin, JP
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (05): : 310 - 313
  • [5] Cerebrospinal fluid in selected inflammatory diseases of the nervous system
    Lehmitz, R
    Mix, E
    Zettl, UK
    NERVENHEILKUNDE, 2002, 21 (02) : 82 - 87
  • [6] CEREBROSPINAL FLUID GLYCOPROTEINS IN DISEASES OF CENTRAL NERVOUS SYSTEM
    DALLOS, E
    OBERMAN, Z
    HERZBERG, M
    STREIFLER, M
    CONFINIA NEUROLOGICA, 1967, 29 (01): : 26 - +
  • [7] A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis
    Christopher Eckstein
    Shiv Saidha
    Michael Levy
    Journal of Neurology, 2012, 259 : 801 - 816
  • [8] A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis
    Eckstein, Christopher
    Saidha, Shiv
    Levy, Michael
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 801 - 816
  • [9] Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis
    Eleonora Virgilio
    Domizia Vecchio
    Ilaria Crespi
    Chiara Puricelli
    Paolo Barbero
    Giulia Galli
    Roberto Cantello
    Umberto Dianzani
    Cristoforo Comi
    Journal of Neurology, 2022, 269 : 3249 - 3257
  • [10] Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
    Martynova, Ekaterina
    Goyal, Mehendi
    Johri, Shikhar
    Kumar, Vinay
    Khaibullin, Timur
    Rizvanov, Albert A.
    Verma, Subhash
    Khaiboullina, Svetlana F.
    Baranwal, Manoj
    MEDIATORS OF INFLAMMATION, 2020, 2020